0 My Account

Absorption of micronized progesterone from a nonliquefying vaginal cream

Kimzey LM et al., 1991

Fertility and Sterility, 56(5), 995-996

Source

Abstract

An improved delivery method to achieve sustained physiological P levels would be useful. Based on this single-dose pharmacokinetic study, micronized P prepared in a nonliquefying vaginal cream holds promise as a convenient method to achieve this goal with a single daily application.

Topics

Reproductive Endocrinology > Progesterone > SupplementationReproductive Endocrinology > Luteal Phase > SupportDiagnostics > Hormone Assays > Progesterone
micronized progesterone vaginal cream, progesterone absorption vaginal, nonliquefying vaginal progesterone, sustained progesterone levels, vaginal progesterone delivery method, progesterone pharmacokinetics vaginal, luteal phase progesterone support, progesterone vaginal cream effectiveness, single dose progesterone study, alternative progesterone administration, progesterone bioavailability vaginal, naprotechnology progesterone support

Cite this article

Kimzey, L. M., Gumowski, J., Merriam, G. R., Grimes GJ Jr, & Nelson, L. M. (1991). Absorption of micronized progesterone from a nonliquefying vaginal cream. *Fertility and sterility*, *56*(5), 995-996.

Keywords

Absorption, Administration, Oral, Adult, Female, Headache/chemically Induced, Humans, Progesterone/administration & Dosage/adverse Effects/blood, Sleep Stages, Vaginal Creams, Foams, and Jellies, Vaginal Creams, Foams, and Jellies, Progesterone,

Related articles

Plasma concentrations of progesterone are higher in the uterine artery than in the radial artery after vaginal administration of micronized progesterone in an oil-based solution to postmenopausal women
Cicinelli E et al., 1998 Fertility and Sterility

OBJECTIVE: To verify the occurrence of preferential distribution of vaginally administered progesterone to the uterus compared with extrapelvic regions in vivo and in humans. DESIGN: Prospective cli...

Reproductive Endocrinology > Progesterone > SupplementationReproductive Endocrinology > Luteal Phase > SupportRRM Methods > NaProTECHNOLOGY > Protocol

Absorption and metabolism of oral progesterone when administered twice daily
Padwick ML et al., 1986 Fertility and Sterility

The absorption, metabolism, and clearance of progesterone (P) from the peripheral circulation were investigated in five postmenopausal women after oral administration of 100 mg at 9:00 A.M. and 200 mg...

Reproductive Endocrinology > Progesterone > SupplementationReproductive Endocrinology > Luteal Phase > SupportDiagnostics > Hormone Assays > Progesterone

Oral micronized progesterone
Driguez PD et al., 1999 Clinical therapeutics

This review sought to examine the rationale for selecting an oral micronized progesterone formulation rather than a synthetic progestin for some of the main indications for progestogens. Unopposed est...

Reproductive Endocrinology > Progesterone > SupplementationReproductive Endocrinology > Luteal Phase > SupportPerimenopause/Menopause > HRT > Alternatives

Targeted drug delivery in gynaecology: the first uterine pass effect
Bulletti C et al., 1997 Human Reproduction (Oxford, England)

The objective was to verify the hypothesis of a 'first uterine pass effect' or direct preferential vagina-to-uterus transport, suggested by the evidence of higher than expected uterine tissue concentr...

Reproductive Endocrinology > Progesterone > SupplementationReproductive Endocrinology > Luteal Phase > SupportDiagnostics > Hormone Assays > Progesterone